BCL-2, a proapoptotic protein, could be overexpressed in hypoxia conditions; its inhibitors can reduce oxidative phosphorylation and eradicate quiescent chemo-resistant AML stem cells (Ashton et al., 2018). The gene discussed is BCL2; the disease is acute myeloid leukemia.